Denti, Michela Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 8.741
AS - Asia 3.271
EU - Europa 2.756
SA - Sud America 477
AF - Africa 62
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.320
Nazione #
US - Stati Uniti d'America 8.602
SG - Singapore 1.419
CN - Cina 670
VN - Vietnam 617
RU - Federazione Russa 436
IT - Italia 413
BR - Brasile 403
SE - Svezia 331
UA - Ucraina 324
FI - Finlandia 305
GB - Regno Unito 221
DE - Germania 183
FR - Francia 156
LV - Lettonia 128
KR - Corea 127
CA - Canada 90
IN - India 86
NL - Olanda 64
BG - Bulgaria 50
BD - Bangladesh 39
HK - Hong Kong 39
ES - Italia 37
ID - Indonesia 33
IQ - Iraq 32
TR - Turchia 31
JO - Giordania 30
ZA - Sudafrica 26
PL - Polonia 25
AR - Argentina 23
JP - Giappone 23
MX - Messico 23
IR - Iran 19
AT - Austria 17
VE - Venezuela 17
PK - Pakistan 16
MY - Malesia 15
LT - Lituania 11
IE - Irlanda 10
AU - Australia 9
EC - Ecuador 8
NP - Nepal 8
UZ - Uzbekistan 8
BE - Belgio 7
CH - Svizzera 7
CL - Cile 7
CO - Colombia 7
EG - Egitto 7
JM - Giamaica 7
KE - Kenya 6
MA - Marocco 6
SA - Arabia Saudita 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
IL - Israele 5
RO - Romania 5
UY - Uruguay 5
AZ - Azerbaigian 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
GR - Grecia 4
HR - Croazia 4
KZ - Kazakistan 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
LK - Sri Lanka 3
NI - Nicaragua 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
TW - Taiwan 3
AL - Albania 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
LB - Libano 2
MM - Myanmar 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
MD - Moldavia 1
Totale 15.312
Città #
Singapore 882
Ashburn 849
Chandler 832
Jacksonville 676
Fairfield 649
San Jose 475
Dallas 350
Woodbridge 322
Wilmington 275
Seattle 267
Houston 262
Santa Clara 262
Ann Arbor 240
Columbus 237
San Mateo 234
Cambridge 213
Princeton 207
Moscow 195
Beijing 184
Helsinki 175
Ho Chi Minh City 166
The Dalles 140
Hanoi 139
New York 139
Riga 128
Seoul 123
Los Angeles 113
Lauterbourg 110
Trento 91
Dearborn 80
Boardman 74
Council Bluffs 65
Buffalo 62
Hefei 61
São Paulo 51
Munich 49
San Diego 48
Sofia 46
Orem 44
North Bergen 41
Milan 39
London 38
Bremen 36
Fremont 34
Da Nang 31
Dong Ket 31
Hong Kong 31
Chicago 28
Delft 28
Lawrence 28
Denver 26
Jakarta 26
Ottawa 26
Rome 26
Haiphong 24
Phoenix 24
Chennai 23
Frankfurt am Main 23
Toronto 22
Warsaw 22
Como 21
Lappeenranta 20
Brooklyn 19
Johannesburg 19
Norwalk 19
Tokyo 19
Stockholm 18
Poplar 17
Redondo Beach 17
San Paolo di Civitate 17
Montreal 16
Guangzhou 15
Manchester 15
Nuremberg 15
Tehran 15
Atlanta 14
Belo Horizonte 14
Biên Hòa 14
Izmir 14
Verona 13
Amsterdam 12
Des Moines 12
Mumbai 12
Boston 11
Kilburn 11
New Delhi 11
Shanghai 11
Washington 11
Badajoz 10
Hillsboro 10
Hải Dương 10
Ipoh 10
Rio de Janeiro 10
Salt Lake City 10
Vienna 10
Ankara 9
Calgary 9
Falkenstein 9
Kunming 9
Turku 9
Totale 10.659
Nome #
The short-term impact of probiotic consumption on the oral cavity microbiome 282
The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer’s Disease Pathogenesis 226
Enhanced microbial diversity in the saliva microbiome induced by short-term probiotic intake revealed by 16S rRNA sequencing on the IonTorrent PGM platform 221
A Cross-Platform Comparison of Affymetrix and Agilent Microarrays Reveals Discordant miRNA Expression in Lung Tumors of c-Raf Transgenic Mice 215
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 207
Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations 202
Statistical analysis of a Bayesian classifier based on the expression of miRNAs 200
A new splicing isoform of Cacna2d4 mimicking the effects of c.2451insC mutation in the retina: Novel molecular and electrophysiological insights 200
Reduced miR-659-3p levels correlate with progranulin increase in hypoxic conditions: Implications for frontotemporal dementia 199
RNA intereference mediated therapy for neurodegenerative diseases 197
DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells 193
Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. A focus on atrial fibrillation 190
An electroporation protocol for efficient DNA transfection in PC12 cells 189
Plasma microRNA profiling distinguishes patients with frontotemporal dementia from healthy subjects 181
microRNAs make the call in cancer personalized medicine 180
microRNA-375 expression distinguishes neuroendocrine from non-neuroendocrine lung tumours in FFPE samples 177
Oligonucleotide therapy 172
A network in FrontoTemporal Dementia - an RNA perspective 172
Comparison of different methods to extract RNA from cardiac tissue for miRNA profiling by qRT-PCR 170
A novel RNA-binding protein from Triturus carnifex identified by RNA-ligand screening with the newt hammerhead ribozyme 169
Delivery is key: Lessons learnt from developing splice-switching antisense therapies 168
Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases 165
New Platform for the Direct Profiling of microRNAs in Biofluids 165
AAV-Mediated Allele-Specific RNA Interference of a Common Dominant Rhodopsin Mutation Causing Retinitis Pigmentosa 164
Splicing-correcting therapeutic approaches for retinal dystrophies: where endogenous gene regulation and specificity matter. 164
Antisense RNA-mediated exon skipping in gene therapy 159
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 158
MiRNA-QC-and-Diagnosis: An R package for diagnosis based on MiRNA expression 158
DNMT3A epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer 158
AAV-mediated Allele-specific RNA interference of a common dominant Rhodopsin mutation causing Retinitis Pigmentosa 156
miR-205 expression levels in non-small cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. 156
MicroRNAs in epithelial ovarian cancer 154
A new vector, based on the polII promoter of U1 snRNA gene, for the expression of siRNAs in mammalian cells 154
A chimeric adeno-associated virus/antisense-U1small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice 154
Identification of new p53 target microRNAs by bioinformatics and functional analysis 154
miR375-3p Distinguishes Low-Grade Neuroendocrine From Non-neuroendocrine Lung Tumors in FFPE Samples 154
Circulating miR-127-3p as a potential biomarker for differential diagnosis in frontotemporal dementia 150
A loxP-containing pol II promoter for RNA interference is reversibly regulated by Cre recombinase 148
Antisense RNA -induced exon-skipping for the gene therapy of Frontotemporal Dementia and Parkinsonism 147
Delivery of oligonucleotide-based therapeutics: challenges and opportunities 147
Upregulation of miR-133b and miR-328 in Patients With Atrial Dilatation: Implications for Stretch-Induced Atrial Fibrillation 146
Functional analysis of miRNAs involved in the regulation of the transcription factors Hoxa9, Hoxa10, Hoxa11 and Pax8 in epithelial ovarian cancer 145
Heterogeneity of Large Cell Carcinoma of the Lung: An Immunophenotypic and miRNA-Based Analysis. 144
MicroRNAs as lung cancer biomarkers 142
Antisense RNA-induced exon-skipping for the gene therapy of frontotemporal dementia and parkinsonism associated with chromosome 17 (ftdp-17) 141
71 nucleotides from the terminal right part of PSTVd is the sufficient minimum of RNA capable of sustaining specific binding to tomato protein Virp1 138
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice 137
Long term benefit of AAV/antisense-mediated exon skipping in dystrophic mice 136
Circulating microRNAs in Neurodegenerative Diseases 136
Antisense RNA -induced exon-skipping for the gene therapy of Frontotemporal Dementia and Parkinsonism 134
MicroRNA and Lung Cancer 132
A study on the newt hammerhead ribozyme : association to RNA-binding proteins and intracellular localisation 131
A study on the newt hammerhead ribozyme : association to RNA-binding proteins and intracellular localisation 131
A vector for siRNA expression in mammalian cells that relies on polII-dependent transcription and produces asymmetric accumulation of one siRNA strand 129
Measurements methods for the development of microRNA-based tests for cancer diagnosis 128
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders 127
MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration 127
Analisi della struttura e dell¿attivit¿ autocatalitica di trascritti dimerici ¿BglII¿ in Triturus 124
Exon Skipping Through Chimeric Antisense U1 snRNAs to Correct Retinitis Pigmentosa GTPase-Regulator (RPGR) Splice Defect 122
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model 120
Fabry Disease: Antisense Therapeutics for intronic variations causing mis-spliced messenger RNA and active-site-specific chaperones (ASSC) for conformational enzyme defects 119
Antisense RNA-mediated exon-skipping for gene therapy 117
mRNA fate: Life and death of the mRNA in the cytoplasm 117
Small RNA molecules of great utility as diagnostic biomarkers in lung cancer 114
New circuits between miRNAs and transcription factors Hoxa9, Hoxa10, Hoxa11 and Pax8: possible identification of therapeutic targets for epithelial ovarian cancer treatment 113
Circulating cell-free microRNAs as biomarkers for neurodegenerative diseases 113
HCS-Splice: A High-Content Screening Method to Advance the Discovery of RNA Splicing-Modulating Therapeutics 111
Il ribozima di tritone: struttura ed applicazioni 111
Short interfering RNAs specific for potato spindle tuber viroid are found in the cytoplasm but not in the nucleus 111
Integrative microRNAome analysis of skeletal muscle of Colossoma macropomum (tambaqui), Piaractus mesopotamicus (pacu), and the hybrid tambacu, based on next-generation sequencing data 110
PMP70 knock-down generates oxidative stress and pro-inflammatory cytokine production in C6 glial cells 109
Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1 108
Replicating potato spindle tuber viroid RNA is accompanied by short RNA fragments that are characteristic of post-transcriptional gene silencing 108
AAV-mediated retinal gene transfer in animal models of retinal degeneration 100
RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: a model system to study PMP70 function 100
Uso di un ribozima di vertebrati per l'inattivazione del gene MGMT in cellule CHO 99
miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia 98
Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1 98
The newt hammerhead ribozyme: structure and applications 98
Preferential silencing of a common dominant rhodopsin mutation does not inhibit retinal degeneration in a transgenic model 98
Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia 97
Virp1 is a host protein with a major role in potato spindle tuber viroid infection in Nicotiana plants 96
News from around the RNA world: new avenues in RNA biology, biotechnology and therapeutics from the 2022 SIBBM meeting 92
Uso di nuove proprietà dell' RNA per la terapia genica di infezioni da HIV = Use of new RNA properties for gene therapy of HIV infections 92
MicroRNAs in epithelial ovarian cancer 92
Towards functional analysis of BVRB, a gene encoding for a viroid binding protein 91
Study on the affinity and specificity of the interaction between Potato Spindle Tuber viroid and tomato protein Virp1 91
SA-ODG platform: a semi-automated and PCR-free method to analyse microRNAs in solid tissues 90
La ribonucleoparticella del ribozima di tritone: fossile molecolare o una nuova particella coinvolta nel ¿processing¿ dell¿RNA? 90
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study 89
Characterisation of the protein components of the newt hammerhead ribozyme RNP 87
Identification of the RNA binding domain of Virp-1 87
U1snRNA-mediated exon skipping for the therapy of Duchenne Muscular Dystrophy: towards a clinical trial 86
Replicating viroid RNA is accompanied by short RNA fragments that are characteristic of posttranscriptional gene silencing 85
Use of new RNA properties for gene therapy of HIV infections 84
Identification of miRNAs Bound to an RNA of Interest by MicroRNA Capture Affinity Technology (miR-CATCH) 84
The motif in the Terminal Right Part of Potato Spindle Tuber Viroid is the determinant of specific in vitro recognition by tomato RNA-binding protein Virp1 83
Virp1, a host factor necessary for replication of nuclear viroids 82
Exon-skipping mediated by the systemic delivery of AAV constructs expressing antisense-snRNAs restores dystrophin and muscular functionality in body-wide skeletal muscles of mdx mice 82
Body-wide rescue of dystrophin and muscle function in mdx mice by antisense-snRNAs mediated exon-skipping 80
Totale 13.657
Categoria #
all - tutte 62.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.210
selected - selezionate 0
volume - volumi 3.550
Totale 67.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 0 0 0 0 0 0 100
2021/20221.284 57 238 5 72 89 25 46 202 75 125 103 247
2022/20231.714 239 198 26 266 191 257 7 117 238 12 76 87
2023/2024658 48 53 38 24 67 153 44 56 6 59 32 78
2024/20252.603 15 29 128 508 121 341 44 178 286 491 203 259
2025/20265.231 437 110 647 779 555 459 919 146 422 429 228 100
Totale 15.576